Table 3.
Recipient and Donor Characteristics of Transplanted Patients by Sex in the New Allocation System
| Variable | Women (n = 1503, 28.3%) | Men (n = 3807, 71.7%) | P Value |
|---|---|---|---|
| Recipient | |||
| Status at transplant | <.001 | ||
| Status 1 | 114 (7.5%) | 369 (9.7%) | |
| Status 2 | 610 (40.6%) | 1943 (51.0%) | |
| Status 3 | 282 (18.8%) | 723 (19.0%) | |
| Status 4 | 381 (25.3%) | 604 (15.9%) | |
| Status 5 | 15 (1.9%) | 26 (0.7%) | |
| Status 6 | 99 (6.6%) | 133 (3.5%) | |
| Ventricular assistance at transplant | |||
| Inotrope only | 600 (40.2%) | 1582 (41.9%) | .27 |
| Temporary MCS | |||
| IABP | 405 (27.1) | 1218 (32.2) | <.001 |
| ECMO | 82 (5.5) | 239 (6.3) | .28 |
| Durable LVAD | 319 (21.8) | 1105 (29.7) | <.001 |
| Donor | |||
| Donor age (y) | 31.9 ± 10.6 | 32.3 ± 10.4 | .218 |
| Female donor sex | 910 (60.5%) | 584 (15.3%) | <.001 |
| White donor race | 942 (63.1%) | 2391 (63.3%) | .456 |
| Ischemic time (h) | 3.40 ± 1.02 | 3.45 ± 1.06 | .148 |
| Distance traveled, miles | 272.8 ± 233.7 | 268.2 ± 235.3 | .521 |
Abbreviations as in Table 1.